Hydroxypethidine

Chemical compound
  • none
Legal statusLegal status
Identifiers
  • Ethyl 4-(3-hydroxyphenyl)-1-methyl-piperidine-4-carboxylate
CAS Number
  • 468-56-4 checkY
PubChem CID
  • 61120
ChemSpider
  • 55068 checkY
UNII
  • W1J43H2B3K
KEGG
  • D12681 checkY
ChEBI
  • CHEBI:135085
ChEMBL
  • ChEMBL1182665
CompTox Dashboard (EPA)
  • DTXSID90196941 Edit this at Wikidata
ECHA InfoCard100.006.738 Edit this at WikidataChemical and physical dataFormulaC15H21NO3Molar mass263.337 g·mol−13D model (JSmol)
  • Interactive image
  • O=C(OCC)C2(c1cccc(O)c1)CCN(C)CC2
InChI
  • InChI=1S/C15H21NO3/c1-3-19-14(18)15(7-9-16(2)10-8-15)12-5-4-6-13(17)11-12/h4-6,11,17H,3,7-10H2,1-2H3 checkY
  • Key:WTJBNMUWRKPFRS-UHFFFAOYSA-N checkY
  (verify)

Hydroxypethidine (Bemidone) is an opioid analgesic that is an analogue of the more commonly used pethidine (meperidine). Hydroxypethidine is slightly more potent than meperidine as an analgesic, 1.5x meperidine in potency,[2] and it also has NMDA antagonist properties like its close relative ketobemidone.[3]

Hydroxypethidine has similar effects to other opioids, and produces analgesia, sedation and euphoria. Side effects can include itching, nausea and potentially serious respiratory depression which can be life-threatening.

Hydroxypethidine is under international control under the Single Convention on Narcotic Drugs 1961 and therefore controlled like morphine in most countries; in the United States it is a Schedule I Narcotic controlled substance with an ACSCN of 9627 and a 2014 annual aggregate manufacturing quota of 2 grams. The salt in use is the hydrochloride, with a free base conversion ratio of 0.878. [4]

See also

References

  1. ^ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
  2. ^ Beckett AH, Casy AF (February 1965). "Analgesics and their antagonists: biochemical aspects and structure-activity relationships". Progress in Medicinal Chemistry. 4: 171–218. doi:10.1016/s0079-6468(08)70169-3. ISBN 9780444533234. PMID 5319798.
  3. ^ Harris I (1949). "The addiction liability of some analogues of meperidine". Journal of Pharmacology and Experimental Therapeutics. 97 (2): 182–190.
  4. ^ "Conversion Factors for Controlled Substances". Diversion Control Division. Drug Enforcement Administration, U.S. Department of Justice. Archived from the original on 2016-03-02. Retrieved 2016-02-27.
  • v
  • t
  • e
μ-opioid
(MOR)
Agonists
(abridged;
full list)
Antagonists
δ-opioid
(DOR)
Agonists
Antagonists
κ-opioid
(KOR)
Agonists
Antagonists
Nociceptin
(NOP)
Agonists
Antagonists
Others


Stub icon

This analgesic-related article is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e